Lantheus Holdings, Inc. Cash and Restricted Cash
Lantheus Holdings, Inc. (LNTH) had Cash and Restricted Cash of $595.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $595.01M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $595.01M; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $500.29M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $360.83M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $383.70M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $595.01M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $595.01M 10-Q · filed 2026-08-06 | $500.29M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $360.83M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $383.70M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $697.26M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $697.26M 10-Q · filed 2026-08-06 | $940.21M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $914.49M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $868.05M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $758.67M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $719.92M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $715.28M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $615.75M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $415.68M 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $472.46M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $417.24M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $258.84M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $173.57M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $107.50M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $100.65M 10-K · filed 2025-02-26 | |
| 2021-09-30 | $93.62M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $93.64M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $71.00M 10-Q · filed 2022-04-29 | |
| 2020-12-31 | $82.69M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $90.14M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $92.45M 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $95.71M 10-Q · filed 2021-05-04 | |
| 2019-12-31 | $92.92M 10-K · filed 2023-02-23 | |
| 2019-09-30 | $78.06M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $56.88M 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $112.06M 10-Q · filed 2020-04-30 | |
| 2018-12-31 | $113.40M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $104.58M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $86.46M 10-Q · filed 2019-07-25 | |
| 2018-03-31 | $73.74M 10-Q · filed 2019-04-30 | |
| 2017-12-31 | $76.29M 10-K · filed 2021-02-25 | |
| 2016-12-31 | $51.18M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |